GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) » Definitions » COGS-to-Revenue

Suzhou Zelgen Biopharmaceuticals Co (SHSE:688266) COGS-to-Revenue : 0.08 (As of Jun. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Suzhou Zelgen Biopharmaceuticals Co COGS-to-Revenue?

Suzhou Zelgen Biopharmaceuticals Co's Cost of Goods Sold for the three months ended in Jun. 2024 was ¥10.3 Mil. Its Revenue for the three months ended in Jun. 2024 was ¥132.5 Mil.

Suzhou Zelgen Biopharmaceuticals Co's COGS to Revenue for the three months ended in Jun. 2024 was 0.08.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Suzhou Zelgen Biopharmaceuticals Co's Gross Margin % for the three months ended in Jun. 2024 was 92.19%.

Suzhou Zelgen Biopharmaceuticals Co COGS-to-Revenue Historical Data

The historical data trend for Suzhou Zelgen Biopharmaceuticals Co's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Suzhou Zelgen Biopharmaceuticals Co COGS-to-Revenue Chart

Suzhou Zelgen Biopharmaceuticals Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
COGS-to-Revenue
Get a 7-Day Free Trial - - 0.03 0.09 0.08

Suzhou Zelgen Biopharmaceuticals Co Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
COGS-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.08 0.08 0.07 0.07 0.08

Suzhou Zelgen Biopharmaceuticals Co COGS-to-Revenue Calculation

Suzhou Zelgen Biopharmaceuticals Co's COGS to Revenue for the fiscal year that ended in Dec. 2023 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=29.212 / 386.439
=0.08

Suzhou Zelgen Biopharmaceuticals Co's COGS to Revenue for the quarter that ended in Jun. 2024 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=10.346 / 132.452
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Suzhou Zelgen Biopharmaceuticals Co  (SHSE:688266) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Suzhou Zelgen Biopharmaceuticals Co's Gross Margin % for the three months ended in Jun. 2024 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 10.346 / 132.452
=92.19 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Suzhou Zelgen Biopharmaceuticals Co COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Suzhou Zelgen Biopharmaceuticals Co's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Suzhou Zelgen Biopharmaceuticals Co Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Suzhou Zelgen Biopharmaceuticals Co Ltd (SHSE:688266) » Definitions » COGS-to-Revenue
Comparable Companies
SZSE:300255 SZSE:002287 SHSE:688443 SZSE:301047 SHSE:688105 SHSE:605116 SHSE:688062 SZSE:002030 SHSE:688076 SHSE:600201 OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX
Traded in Other Exchanges
N/A
Address
No.209 Chenfeng Road, Yushan Town, Jiangsu Province, Kunshan, CHN
Website
http://www.zelgen.com
Suzhou Zelgen Biopharmaceuticals Co Ltd is engaged in research and development of new chemical and biological drugs for various therapeutic areas, including tumors, bleeding and blood diseases, and hepatobiliary diseases.
Executives
Zhang Bin Core technical personnel
Huang Gang senior management
Lv Bin Hua Directors, senior managers, core technical personn
Lu Hui Ping Directors, senior managers
Gao Qing Ping senior management
Wu Ji Sheng Directors, senior managers, core technical personn
Zhang Jun Li senior management
Wu Li Qing Core technical personnel
Core technical personnel
Sheng Ze Lin Directors, senior managers, core technical personn

Suzhou Zelgen Biopharmaceuticals Co Headlines

No Headlines